CSS LLC’s Inhibrx INBX Stock Holding History

CSS LLC’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,875	Closed	-$214K	–	1004
2024 Q4	$214K	Sell	13,875 -33,125	-70%	-$505K	0.01%	763
2024 Q3	$736K	Sell	47,000 -31,625	-40%	-$444K	0.03%	378
2024 Q2	$1.11M	Buy	+78,625	New	+$1.23M	0.06%	253

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

CSS LLC's INBX Position: Q1 2025 in Review

CSS LLC sold out of Inhibrx (INBX) in Q1 2025, closing a stake of 51,712 shares — an estimated $796K sold.

CSS LLC first reported a position in INBX in Q2 2024 and held it in 3 quarters. The position peaked at $1.57M in Q2 2024. 92 funds tracked by Wall St. Rank hold INBX as of Q1 2025.

CSS LLC reported no remaining Inhibrx position as of Q1 2025 after selling out during the quarter.
CSS LLC sold 51,712 Inhibrx shares in Q1 2025, an estimated $796K.
CSS LLC first reported a position in Inhibrx in Q2 2024 and held it in 3 quarters.
CSS LLC's Inhibrx position peaked at $1.57M in Q2 2024.
92 funds tracked by Wall St. Rank held Inhibrx as of Q1 2025.

Based on CSS LLC's 13F filing for Q1 2025, filed 15 May 2025.